Inclusion Body Myositis: Boundaries That May Define Transition to Treatment Refractoriness
- PMID: 36195454
- DOI: 10.1212/WNL.0000000000201506
Inclusion Body Myositis: Boundaries That May Define Transition to Treatment Refractoriness
Comment on
-
Morphologic and Molecular Patterns of Polymyositis With Mitochondrial Pathology and Inclusion Body Myositis.Neurology. 2022 Nov 15;99(20):e2212-e2222. doi: 10.1212/WNL.0000000000201103. Epub 2022 Oct 4. Neurology. 2022. PMID: 36195449
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical